Biotech Investing BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025 10 December
Biotech Investing BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout 09 December
Biotech Investing BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025 02 December
